Your browser does not support iframes.
Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Pfizer, Inc.
(NY:
PFE
)
28.70
USD
-0.00 (-0.02%)
Streaming Delayed Price
/ Updated:
2:12 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Pfizer, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Merck Hangs Tough
Today 12:31 EDT
This blue chip pharmaceutical firm has taken it on the chin lately, but several new drugs in the pipeline should hold it in good stead.
Read More
from
Update Content Feed for Financial Content
SAC's Martoma says U.S. impedes defense in fraud case
Today 11:20 EDT
Former SAC Capital Advisors portfolio manager Mathew Martoma said the government is impeding his ability to defend against criminal insider trading charges by trying to link him to an alleged...
Read More
from
FOX News
Pfizer (PFE) Breaks Through Support at $28.56
Today 10:41 EDT
from
Comtex SmarTrend® News Briefs
Profitable Trading Secrets Revealed in F, GE, PFE and ELN
Today 9:00 EDT
from
Marketwired News Releases
Forget Yahoo-Tumblr – This $8.5 billion Deal is the REAL Buyout Story
Today 2:45 EDT
Read More
category
NASDAQ:WCRX
,
NYSE:MRK
,
NASDAQ:YHOO
, and 3 more.
from
InvestorPlace - Latest Headlines
Pfizer halts study of lymphoma drug unlikely to help survival
May 20, 2013
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive...
Read More
category
companyNews
from
Reuters: Company News
Pfizer (PFE) Discontinues Phase 3 Study of Inotuzumab Ozogamicin
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8355790 for the full story.
Read More
from
StreetInsider.com News Articles
Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
May 20, 2013
from
Business Wire News Releases
6 Healthy Products That Aren't
May 20, 2013
False claims about amazing healthful benefits are still a surefire way for companies to move merchandise. Don't fall for these "breakthrough" products.
Read More
category
SKX
,
JNJ
,
WMT
, and 2 more.
from
Minyanville Headlines
March 2014 Options Now Available For Pfizer Inc (PFE)
May 20, 2013
Investors in Pfizer Inc (PFE) saw new options become available today, for the March 2014 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value,...
Read More
category
Stocks
from
Market News Video
Noteworthy ETF Inflows: VTV, GE, PFE, T
May 20, 2013
Symbols mentioned in this story: VTV, GE, PFE, T Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can...
Read More
category
ETFs
from
ETF Channel
More Details about Hisun-Pfizer and Merck-Simcere JVs
May 20, 2013
In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were...
Read More
from
ChinaBio® Today
Medtronic Q4 Earnings: Modest Revenue Growth And Gross Margin Pressure Expected
May 20, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Pfizer Earnings Review: 20 Days after Announcement Shares Down 0.4% (PFE)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Reveal Insider Trading for Ford Motor, Autodesk, Pfizer, Oracle, Exxon Mobil, and Home Depot
May 20, 2013
from
PR Newswire
Pharma's R&D Deals With Foundations May Negatively Impact Image
May 20, 2013
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of...
Read More
category
NASDAQ:VRTX
,
NYSE:PFE
from
Forbes Real Time
The Straight Truth, Investing in GRPN, INTC and PFE
May 18, 2013
from
Marketwired News Releases
DOW LAGGARDS: AT&T Inc, Merck & Co., Inc., Pfizer Inc., Wal-Mart Stores Inc.
May 17, 2013
Huntington Beach, CA -- (SBWIRE) -- 05/17/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,...
Read More
from
SBWire - Latest Press Releases
Cheerleaders: Look Beyond Pharma For Jobs
May 16, 2013
category
AZN
,
ABBV
,
TSPT
, and 5 more.
from
YCharts
(TEVA) Thoughts from Israel
May 16, 2013
Israel is a difficult place to live. As it is surrounded by its enemies, military service is... Visit StockBlogHub to view complete post.
Read More
category
Pfizer Inc/
,
TEVA
,
Healthcare
, and 3 more.
from
Stock Blog Hub
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
May 16, 2013
* Novartis' one-third stake in Roche built up under Vasella
Read More
category
companyNews
from
Reuters: Company News
May 16, 2013 - Today's Industrial Market News from Industrialinfo.com
May 16, 2013
Stories featured in this segment: Pfizer Incorporated (NYSE:PFE), ThyssenKrupp AG (OTC:TYEKF)
Read More
from
Industrial Info Daily News Podcast
May 16, 2013 - Today's Industrial Market News from Industrialinfo.com
May 16, 2013
Stories featured in this segment: Pfizer Incorporated (NYSE:PFE), ThyssenKrupp AG (OTC:TYEKF)
Read More
from
Industrial Info Daily News Podcast
Close to the 50 Day Moving Average: Pfizer
May 16, 2013
New York, May 16th (TradersHuddle.com) - Pfizer, Inc. ( NYSE:PFE ) closed the trading day at $29.56, near its 50 day moving average that is set at $29.21. Pfizer's price action is just above this...
Read More
from
TradersHuddle.com
Zoetis (ZTS) Reveise FDA Approval of APOQUEL
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8345827 for the full story.
Read More
from
StreetInsider.com News Articles
Pharmaceutical-Biotech Industry to Pull Plug on 30 North American Sites in 2013, an Industrial Info News Alert
May 16, 2013
from
Marketwired News Releases
Strategy Behind Our Success, We Get in Early: BSX, AINV, PFE and SPF
May 16, 2013
from
Marketwired News Releases
Examining Options & Block Trading Activity for Pfizer (PFE)
May 16, 2013
NEW YORK (AVAFIN) -- Block trading activities for shares of Pfizer reveal that 50 ...
Read More
from
AVAFIN
Pharmaceutical-Biotech Industry to Pull Plug on 30 North American Sites in 2013
May 16, 2013
SUGAR LAND--May 16, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In a case of bad news being not quite as bad as it could be, the Pharmaceutical-Biotech Industry is...
Read More
from
IIR Industry News Alerts
Finding the Next Big Blockbuster Drug
May 15, 2013
from
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.